These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 31449673)

  • 21. Genetic analysis of single disseminated tumor cells in the lymph nodes and bone marrow of patients with head and neck squamous cell carcinoma.
    Sproll KC; Schorn LK; Reising B; Schumacher S; Lommen J; Kübler NR; Knoefel WT; Beier M; Neves RP; Behrens B; Horny K; Stoecklein NH
    Mol Oncol; 2022 Jan; 16(2):333-346. PubMed ID: 34719102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microfluidic Isolation of Disseminated Tumor Cells from the Bone Marrow of Breast Cancer Patients.
    Volmer LL; Önder CE; Volz B; Singh AR; Brucker SY; Engler T; Hartkopf AD; Koch A
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the prognostic significance of disseminated tumor cells in the bone marrow of primary, non-metastatic breast cancer patients after a 7-year follow-up.
    Hoffmann O; Schroer-Zuendorf IA; Kasimir-Bauer S; Oberhoff C; Kimmig R; Heubner M
    Arch Gynecol Obstet; 2015 Nov; 292(5):1117-25. PubMed ID: 25986892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A microfluidic-based filtration system to enrich for bone marrow disseminated tumor cells from breast cancer patients.
    Pillai SG; Siddappa CM; Ma C; Snider J; Kaushal M; Watson MA; Aft R
    PLoS One; 2021; 16(5):e0246139. PubMed ID: 33989287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The detection and isolation of viable prostate-specific antigen positive epithelial cells by enrichment: a comparison to standard prostate-specific antigen reverse transcriptase polymerase chain reaction and its clinical relevance in prostate cancer.
    Pfitzenmaier J; Ellis WJ; Hawley S; Arfman EW; Klein JR; Lange PH; Vessella RL
    Urol Oncol; 2007; 25(3):214-20. PubMed ID: 17483018
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical outcome with correlation to disseminated tumor cell (DTC) status after DTC-guided secondary adjuvant treatment with docetaxel in early breast cancer.
    Naume B; Synnestvedt M; Falk RS; Wiedswang G; Weyde K; Risberg T; Kersten C; Mjaaland I; Vindi L; Sommer HH; Sætersdal AB; Rypdal MC; Bendigtsen Schirmer C; Wist EA; Borgen E
    J Clin Oncol; 2014 Dec; 32(34):3848-57. PubMed ID: 25366688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disseminated tumor cells from the bone marrow of patients with nonmetastatic primary breast cancer are predictive of locoregional relapse.
    Hartkopf AD; Wallwiener M; Fehm TN; Hahn M; Walter CB; Gruber I; Brucker SY; Taran FA
    Ann Oncol; 2015 Jun; 26(6):1155-1160. PubMed ID: 25791636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased expression of putative cancer stem cell markers in the bone marrow of prostate cancer patients is associated with bone metastasis progression.
    Ricci E; Mattei E; Dumontet C; Eaton CL; Hamdy F; van der Pluije G; Cecchini M; Thalmann G; Clezardin P; Colombel M
    Prostate; 2013 Dec; 73(16):1738-46. PubMed ID: 24115186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Persistent tumor cells in bone marrow of non-metastatic breast cancer patients after primary surgery are associated with inferior outcome.
    Tjensvoll K; Oltedal S; Heikkilä R; Kvaløy JT; Gilje B; Reuben JM; Smaaland R; Nordgård O
    BMC Cancer; 2012 May; 12():190. PubMed ID: 22640166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The biology and clinical implications of prostate cancer dormancy and metastasis.
    Morrissey C; Vessella RL; Lange PH; Lam HM
    J Mol Med (Berl); 2016 Mar; 94(3):259-65. PubMed ID: 26489605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of ibandronate on disseminated tumor cells in the bone marrow of patients with primary breast cancer: a pilot study.
    Hoffmann O; Aktas B; Goldnau C; Heubner M; Oberhoff C; Kimmig R; Kasimir-Bauer S
    Anticancer Res; 2011 Oct; 31(10):3623-8. PubMed ID: 21965788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single cell mutational analysis of PIK3CA in circulating tumor cells and metastases in breast cancer reveals heterogeneity, discordance, and mutation persistence in cultured disseminated tumor cells from bone marrow.
    Deng G; Krishnakumar S; Powell AA; Zhang H; Mindrinos MN; Telli ML; Davis RW; Jeffrey SS
    BMC Cancer; 2014 Jun; 14():456. PubMed ID: 24947048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Presence of disseminated tumor cells in bone marrow correlates with tumor stage and nodal involvement in cervical cancer patients.
    Fehm T; Banys M; Rack B; Jäger B; Hartkopf A; Taran FA; Janni W
    Int J Cancer; 2014 Feb; 134(4):925-31. PubMed ID: 23921989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disseminated tumor cells as selection marker and monitoring tool for secondary adjuvant treatment in early breast cancer. Descriptive results from an intervention study.
    Synnestvedt M; Borgen E; Wist E; Wiedswang G; Weyde K; Risberg T; Kersten C; Mjaaland I; Vindi L; Schirmer C; Nesland JM; Naume B
    BMC Cancer; 2012 Dec; 12():616. PubMed ID: 23259667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostate-specific markers to identify rare prostate cancer cells in liquid biopsies.
    van der Toom EE; Axelrod HD; de la Rosette JJ; de Reijke TM; Pienta KJ; Valkenburg KC
    Nat Rev Urol; 2019 Jan; 16(1):7-22. PubMed ID: 30479377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative evaluation of cell-free tumor DNA in blood and disseminated tumor cells in bone marrow of patients with primary breast cancer.
    Schwarzenbach H; Pantel K; Kemper B; Beeger C; Otterbach F; Kimmig R; Kasimir-Bauer S
    Breast Cancer Res; 2009; 11(5):R71. PubMed ID: 19772563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of single disseminated prostate cancer cells reveals tumor cell heterogeneity and identifies dormancy associated pathways.
    Chéry L; Lam HM; Coleman I; Lakely B; Coleman R; Larson S; Aguirre-Ghiso JA; Xia J; Gulati R; Nelson PS; Montgomery B; Lange P; Snyder LA; Vessella RL; Morrissey C
    Oncotarget; 2014 Oct; 5(20):9939-51. PubMed ID: 25301725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disseminated tumour cells from the bone marrow of early breast cancer patients: Results from an international pooled analysis.
    Hartkopf AD; Brucker SY; Taran FA; Harbeck N; von Au A; Naume B; Pierga JY; Hoffmann O; Beckmann MW; Rydén L; Fehm T; Aft R; Solà M; Walter V; Rack B; Schuetz F; Borgen E; Ta MH; Bittner AK; Fasching PA; Fernö M; Krawczyk N; Weilbaecher K; Margelí M; Hahn M; Jueckstock J; Domschke C; Bidard FC; Kasimir-Bauer S; Schoenfisch B; Kurt AG; Wallwiener M; Gebauer G; Klein CA; Wallwiener D; Janni W; Pantel K
    Eur J Cancer; 2021 Sep; 154():128-137. PubMed ID: 34265505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection and isolation of human disseminated tumor cells in the murine bone marrow stem cell niche.
    Shiozawa Y; Taichman RS; Keller ET
    Methods Mol Biol; 2013; 1035():207-15. PubMed ID: 23959994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tracing the origin of disseminated tumor cells in breast cancer using single-cell sequencing.
    Demeulemeester J; Kumar P; Møller EK; Nord S; Wedge DC; Peterson A; Mathiesen RR; Fjelldal R; Zamani Esteki M; Theunis K; Fernandez Gallardo E; Grundstad AJ; Borgen E; Baumbusch LO; Børresen-Dale AL; White KP; Kristensen VN; Van Loo P; Voet T; Naume B
    Genome Biol; 2016 Dec; 17(1):250. PubMed ID: 27931250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.